Methods and compositions for combination RNAi therapeutics

Details for Australian Patent Application No. 2005213485 (hide)

Owner Intradigm Corporation

Inventors Li, Bao-Jian; Lu, Patrick Y.; Xie, Frank Y.; Woodle, Martin C.

Agent Davies Collison Cave

Pub. Number AU-A-2005213485

PCT Pub. Number WO2005/076999

Priority 60/541,776 05.02.04 US

Filing date 7 February 2005

Wipo publication date 25 August 2005

International Classifications

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/076999 Priority application(s): WO2005/076999

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005213493-Methods of diagnosing and treating preeclampsia or eclampsia

2005213484-RNAi therapeutics for treatment of eye neovascularization diseases